Probenecid + Colchicine Rx
Generic Name and Formulations:
Probenecid 500mg, colchicine 0.5mg; scored tabs.
Various generic manufacturers
Indications for Probenecid + Colchicine:
Chronic gouty arthritis.
1 tab daily for 1 week, then 1 tab twice daily thereafter. Renal impairment, dose adjustments: see literature.
Acute gouty attack. Blood dyscrasias. Uric acid kidney stones. Children <2 yrs of age. Pregnancy. Concomitant salicylates (antagonizes uricosuric effect).
History of peptic ulcer. Spastic colon. GI, renal, hepatic, or hematological disorders. G6PD deficiency. Monitor blood counts in long-term therapy. Maintain adequate hydration. Alkalization of urine may be required. Debilitated. Elderly. Nursing mothers.
Uricosuric + antiinflammatory.
Affects renal clearance of many drugs (esp. penicillins). Potentiates methotrexate (monitor and reduce methotrexate dose). May potentiate thiopental, ketamine, NSAIDs, oral sulfonylureas, acetaminophen, lorazepam, rifampin, other sulfonamides. Pyrazinamide antagonizes uricosuric effect. May cause falsely high readings of theophylline levels, or false (+) RBC or hemoglobin in urine.
Headache, dizziness, GI upset, diarrhea, urinary frequency, sore gums, uric acid kidney stones, dermatitis, hematuria, renal colic, fever, peripheral neuritis, myopathy, anemia, blood dyscrasias, hemolytic anemia, purpura, bone marrow depression; rare: severe allergic reactions, anaphylaxis.
Formerly known under the brand name Colbenemid.
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments